InvestorsHub Logo
Followers 16
Posts 1062
Boards Moderated 0
Alias Born 09/01/2019

Re: Money $hot post# 15988

Friday, 05/27/2022 4:46:02 PM

Friday, May 27, 2022 4:46:02 PM

Post# of 16697
Yes, he said $.20 valuation after top line data showed no 'magic wand' for COVID. Neither did Remdesivir, but they sure glommed most Clinical Trials pushing their drug and sold millions of doses around the world with low success compared to their Trial's primary and secondary endpoints and safety issues, IMO. AGN couldnt afford a Phase 3 WITHOUT a 'magic wand', IMO. COVID had vaccines being pushed. AGN needed a new path...IMHFO-.*
( A.U recs on Gld? LOL)
anyway
I took his advice at the time and 'joined the crowd' with many of my long held shares in that obvious rec. Pretty easy call. Bought the pre R/S sale as I feel different about the future of AGN's prospects than you. Maybe I can even buy 100 shares and move the pps 5% like today.

...GLTA...





Rem = Gilead / Wuhan Virologic Institute / coronavirus and batshit soup...